Aethlon Medical (NASDAQ:AEMD) is scheduled to release its earnings data after the market closes on Thursday, June 24th. Analysts expect Aethlon Medical to post earnings of ($0.20) per share for the quarter.
Shares of AEMD opened at $5.50 on Wednesday. The stock’s 50 day simple moving average is $2.71. Aethlon Medical has a 1-year low of $1.22 and a 1-year high of $12.49. The stock has a market cap of $66.72 million, a PE ratio of -2.94 and a beta of 0.49.
AEMD has been the topic of a number of analyst reports. Maxim Group raised their target price on shares of Aethlon Medical from $6.00 to $11.00 and gave the stock a “buy” rating in a research report on Tuesday, June 15th. HC Wainwright initiated coverage on shares of Aethlon Medical in a research report on Tuesday, June 1st. They set a “buy” rating and a $5.00 target price on the stock.
About Aethlon Medical
Aethlon Medical, Inc, a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system.
Read More: Cash Flow Analysis in Stock Selection